Molecular imaging of cell death in an experimental model of Parkinson's disease with a novel apoptosis-targeting peptide

Molecular Imaging and Biology

Volumn 14, Issue 2, 2012, Pages 147-155

  Lee, Min Jeong ^a   Wang, Kai ^a   Kim, In San ^a   Lee, Byung Heon ^a   Han, Hyung Soo ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Apoptosis; Apoptosis targeting peptide; In vivo imaging; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMANTADINE; APOPEP 1 PROTEIN; CELL PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; CELL LOSS; CONTROLLED STUDY; DISEASE MARKER; DOPAMINERGIC NERVE CELL; DRUG EFFECT; EX VIVO STUDY; FLUORESCENCE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOLECULAR IMAGING; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TARGETING; SCREENING TEST; SIGNAL TRANSDUCTION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; AMANTADINE; ANIMALS; APOPTOSIS; BRAIN; CELL COUNT; DISEASE MODELS, ANIMAL; FLUORESCEIN-5-ISOTHIOCYANATE; IN SITU NICK-END LABELING; INJECTIONS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR IMAGING; NEURONS; PARKINSON DISEASE; PEPTIDES; PROTEIN TRANSPORT; TYROSINE 3-MONOOXYGENASE;

MUS;

EID: 84861478661     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-011-0497-z     Document Type: Article

References (23)

1. von Bohlen Und Halbach O (2005) Modeling neurodegenerative diseases in vivo review. Neurodegener Dis 2(6):313-320
2. George JL, Mok S, Moses D et al (2009) Targeting the progression of Parkinson's disease. Curr Neuropharmacol 7(1):9-36
3. Naoi M, Maruyama W, Yi H et al (2009) Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival. J Neural Transm 116(11):1371-1381
4. Winklhofer KF, Haass C (2010) Mitochondrial dysfunction in Parkinson's disease. Biochim Biophys Acta 1802(1):29-44
5. Levy OA, Malagelada C, Greene LA (2009) Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 14(4):478-500
6. Tatton WG, Chalmers-Redman R, Brown D, Tatton N (2003) Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann Neurol 53 (Suppl 3):S61-S70, discussion S70-72
7. Tait JF (2008) Imaging of apoptosis. J Nucl Med 49(10):1573-1576
8. Smith G, Nguyen QD, Aboagye EO (2009) Translational imaging of apoptosis. Anticancer Agents Med Chem 9(9):958-967
9. Blankenberg FG (2008) In vivo detection of apoptosis. J Nucl Med 49 (Suppl 2):81S-95S
10. De Saint-Hubert M, Prinsen K, Mortelmans L, Verbruggen A, Mottaghy FM (2009) Molecular imaging of cell death. Methods 48 (2):178-187
11. Fischer K, Voelkl S, Berger J et al (2006) Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. Blood 108(13):4094-4101 (Pubitemid 44913280)
12. Smrz D, Draberova L, Draber P (2007) Non-apoptotic phosphatidylserine externalization induced by engagement of glycosylphosphatidylinositol-anchored proteins. J Biol Chem 282(14):10487-10497 (Pubitemid 47093455)
13. Wang K, Purushotham S, Lee JY et al (2010) In vivo imaging of tumor apoptosis using histone H1-targeting peptide. J Control Release 148(3):283-291
14. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39(6):889-909 (Pubitemid 37130207)
15. Schapira AH (2010) Complex I: inhibitors, inhibition and neurodegeneration. Exp Neurol 224(2):331-335
16. Bredesen DE, Rao RV, Mehlen P (2006) Cell death in the nervous system. Nature 443(7113):796-802 (Pubitemid 44622684)
17. Jenner P, Olanow CW (2006) The pathogenesis of cell death in Parkinson's disease. Neurology 66(10 Suppl 4):S24-S36
18. Liang CL, Wang TT, Luby-Phelps K, German DC (2007) Mitochondria mass is low in mouse substantia nigra dopamine neurons: implications for Parkinson's disease. Exp Neurol 203(2):370-380 (Pubitemid 46149588)
19. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8(4):382-397
20. Novikova L, Garris BL, Garris DR, Lau YS (2006) Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Neuroscience 140(1):67-76 (Pubitemid 43668437)
21. Ruiz-Vela A, Korsmeyer SJ (2007) Proapoptotic histone H1.2 induces CASP-3 and -7 activation by forming a protein complex with CYT c, APAF-1 and CASP-9. FEBS Lett 581(18):3422-3428 (Pubitemid 47048192)
22. Ohsawa S, Hamada S, Yoshida H, Miura M (2008) Caspase-mediated changes in histone H1 in early apoptosis: prolonged caspase activation in developing olfactory sensory neurons. Cell Death Differ 15(9):1429-1439
23. Reis J, John D, Heimeroth A et al (2006) Modulation of human motor cortex excitability by single doses of amantadine. Neuropsychopharmacology 31(12):2758-2766 (Pubitemid 44764172)